Clinical trial Recruiting at 1 site Interventional Ages 7 to 18

Effects of intermittent dietary restriction on heart and metabolic health in children

Official title: Effects of Intermittent Dietary Restriction on Cardiometabolic Risk in School-aged Children: A Randomized Controlled Trial

Run by Children's Hospital of Fudan University · NCT06500078 · Data updated 2026-11-12

This study tests if different types of intermittent diets can help school-aged children with heart and metabolic health issues feel better compared to regular health education.

More Cardiovascular-kidney-metabolic Syndrome trials

Quick facts

Study typeInterventional
Ages7 Years to 18 Years
SexAll
Enrollment324 (estimated)
SponsorChildren's Hospital of Fudan University
Academic / other
Locations1 site (Shanghai)
StatusRecruiting
StartedJuly 13, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedOctober 13, 2026
Trial IDNCT06500078 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 7-18 years with at least one cardiometabolic abnormality such as prediabetes, lipid abnormalities, or elevated blood pressure.

Probably not a fit

Patients with severe health conditions like heart failure, liver or kidney disease, or those who have undergone bariatric surgery may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial evaluates the health benefits of intermittent dietary restrictions, including low-carbohydrate and calorie restriction diets, in school-aged children with cardiometabolic risk factors. Participants will be assigned to either an intermittent low-carbohydrate diet, an intermittent calorie restriction diet, or a general health education program over a 12-month period. The study aims to determine the effectiveness of these dietary approaches in improving cardiometabolic health compared to standard dietary guidelines. The intervention phase lasts for three months, followed by a nine-month self-maintenance phase.

Why it matters

Potential benefit: If successful, this study could provide effective dietary strategies to reduce cardiometabolic risks in children, potentially improving their long-term health outcomes.

How similar studies have gone: While intermittent dietary restrictions have shown effectiveness in adults, evidence in pediatric populations is limited, making this approach relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Aged 7-18 years at baseline.
* At least one of the following cardio-metabolic abnormalities:

  1. Prediabetes (Impaired fasting glucose: 5.6 ≤ fasting blood glucose level ≤ 6.9 mmol/L; or Impaired glucose tolerance: 7.8 ≤ blood glucose level after 2 hours postprandial ≤ 11.0 mmol/L).
  2. Lipid abnormalities (High-density lipoprotein cholesterol ≤ 1.04 mmol/L; or Low-density lipoprotein cholesterol ≥ 3.37 mmol/L; or Triglycerides ≥ 1.70 mmol/L, or Total cholesterol ≥ 5.18 mmol/L).
  3. Elevated blood pressure (Systolic/diastolic blood pressure consistently higher than the 90th percentile for gender, age, and height; or systolic/diastolic blood pressure ≥ 120/80 mmHg).

Exclusion Criteria:

* Previously diagnosed with heart failure, severe malnutrition, immune deficiency, liver or kidney disease, cancer, or other diseases deemed unsuitable for participation.
* Had a history of bariatric surgery.
* Used weight loss pills or supplements in the last three months.
* Other situations unsuitable for participation.

Where it's running

  • Children's Hospital of Fudan University
    Shanghai, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.